<DOC>
	<DOCNO>NCT00748098</DOCNO>
	<brief_summary>The purpose study assess efficacy safety GSK1838262 extend release tablet treatment patient Restless Legs Syndrome associate sleep disturbance .</brief_summary>
	<brief_title>Polysomnography Study GSK1838262 Extended Release Tablets Versus Placebo RLS Associated Sleep Disturbance</brief_title>
	<detailed_description>Double-blind , multi-center , placebo-controlled , 2-period crossover study assess efficacy safety gabapentin enacarbil ( GEn ; GSK1838262 ; XP13512 ) extend release tablet adults Restless Legs Syndrome ( RLS ) -associated sleep disturbance . One hundred thirty-six ( 136 ) adult subject RLS-associated sleep disturbance periodic limb movement ( PLM ) randomize 23 center United States . Subjects meet eligibility criterion randomize receive treatment sequence GEn : placebo placebo : GEn. Investigational product take food approximately 5pm . Investigational product dose 600mg/day x3 day follow 1200mg/day x25 day 4-week treatment period . There 1-week taper 600mg treatment period follow 1-week washout treatment . Polysomnography ( PSG ) use objectively evaluate change sleep PLMs .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Inclusion criterion : Provided write informed consent . Diagnosed primary RLS use International RLS Study Group Diagnostic Criteria total score 15 great International RLS ( IRLS ) Rating Scale significant sleep disturbance indicate Item 4 IRLS rating scale . Have history RLS symptoms least 15 nights/month . Minimum average 15 Periodic Limb Movements Sleep per hour ( measure use actigraphy ) . Exclusion criterion : Secondary RLS Primary sleep disorder Sleep apnea Have medical condition may impact efficacy assessment may present safety concern . Pregnant lactate woman childbearing potential practicing acceptable method birth control . Use prohibit medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>PSG</keyword>
	<keyword>Restless Legs Syndrome</keyword>
	<keyword>gabapentin enacarbil</keyword>
	<keyword>XP13512</keyword>
	<keyword>GSK1838262</keyword>
	<keyword>sleep disturbance</keyword>
	<keyword>RLS</keyword>
	<keyword>polysomnography</keyword>
</DOC>